Major techs and semiconductor companies give up on early-trading gains after the report stating that U.S. Commerce Department plans to revoke waivers allowing South Korean and Taiwanese chipmakers (ex. Samsung, SK Hynix, TSMC) to export American semiconductor equipment to their factories in China without individual licenses.
The Philadelphia Semiconductor Index is down 0.8% after the report release. Lam Research's shares took the biggest hit (-3.13%), with other key players also trading in the red (Nvidia: -1.1%; Intel: -1.7%, Broadcom: -1.6%, Qualcomm: -1.3%).
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appThe move aims to tighten controls on U.S. technology transfers to China, mirroring China’s export restrictions on rare-earth materials, and reflects a broader national-security push to limit China’s technological advances. Diplomatically, this decision risks undermining the recent fragile U.S.–China trade truce and straining relations with key U.S. allies South Korea and Taiwan.
The Chinese fabs affected produce essential chips used in cars, electronics, and other goods, though generally not the most advanced technologies. While immediate shutdowns are unlikely, tighter restrictions could disrupt operations and global supply chains over time. The companies may seek individual licenses or shift to Japanese and European suppliers, but internal U.S. government disagreement and fears of empowering Chinese rivals add complexity to the policy’s impact.
The US100 fell sharply below key resistance levels, delaying any potential recovery toward February’s all-time highs. Source: xStation5
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
